Novel and Exceptional Technology and Research Advisory Committee Meeting

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research and discuss the next steps regarding the current charge to the committee, delivered in August 2023

NIH Videocast

https://videocast.nih.gov/watch=55348

Draft Agenda

NExTRAC November 2024 Draft Meeting Agenda

Public Comments

Any interested person may file written comments by forwarding the statement to [email protected] at least two business days prior to the meeting date. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.

Novel and Exceptional Technology and Research Advisory Committee Meeting

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will receive an update from the Working Group on Engaging the Public as Partners in Clinical Research and discuss the next steps regarding the current charge to the committee, delivered in August 2023 (Federal Register Notice).

Registration is not required to view the webcast.

The materials below contain content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: [email protected].

NIH Videocast

https://videocast.nih.gov/watch=54917

Agenda

NExTRAC June 17, 2024 Agenda

Public Comments

Any interested person may file written comments by e-mailing [email protected] at least two business days prior to the meeting date. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.

Additional Meeting Materials

Virtual Webinar & Listening Session on Clinical Research Engagement

The National Institutes of Health (NIH) and the Center for Information and Study on Clinical Research Participation (CISCRP) will be hosting a virtual webinar and listening session as part of a larger effort on improving public engagement in clinical research. During this webinar, NIH and CISCRP will provide background on clinical research and research engagement, before opening to public comments as part of a listening session.

Webcast:

https://videocast.nih.gov/watch=54978

Agenda

ENGAGE Listening Session July 17, 2024 Agenda

Slides

What is Engagement in Clinical Research